Shafren, D. R., Farrelly, M., Croft, A. J., Davies, B., Stewart, J., Ingham, R., Quah, M. Y., Au, G., Hersey, P.. Wiley-Blackwell Publishing; 2011. CAVATAK (Coxsackievirus A21) displays potent oncolytic activity in BRAFV600E mutant melanoma cells resistant to selective BRAF kinase inhibitors.